Navigation Links
Rensselaer receives more than $2 million from New York State to fund stem cell research
Date:3/23/2009

we do not want them to become cancerous." Researchers currently hypothesize the niche surrounding the stem cell could control the difference between cure and cancer.

The glyco niche is one aspect of the entire niche or environment that surrounds each stem cell. Understanding exactly what comprises this specific niche could be the key to controlling the development of stem cells in the body and preventing them from maturing into potentially dangerous cell types, Linhardt said.

Linhardt has already determined that the carbohydrate structure surrounding an embryonic stem cell gets much larger and more complex as the cell matures. With this funding, the team will now analyze human embryonic stem cells throughout their growth to map how exactly the structure of the glyco niche changes as they mature. They will then determine if the function of the stem cell can be controlled by simply modifying its surrounding glyco niche using a range of new technologies that delve into molecular level changes that take place within the stem cells as they grow, including a cell-based, high-throughput microarray technology developed in the Dordick lab.

Genetic Control of Stem Cells

Ferland's lab will delve into the interior of the cell to understand how specific genes control stem cell function. He will partner with Volney Sheen at Harvard Medical School on the research.

Ferland is particularly interested in two classes of genes known as filamins and formins. These genes have been shown to be very important in controlling the formation of both brain and bone stem cells. Mutation of these genes results in abnormal stem cell growth leading to nodules in the neurons of the brain, a condition known as periventricular heterotopia and a progressive shortening of bones known as skeletal chondrodysplasias. These genetic disorders, although rare in humans, provide important insight into how stem cells grow and change during our development, a
'/>"/>

Contact: Gabrielle DeMarco
demarg@rpi.edu
518-276-6542
Rensselaer Polytechnic Institute
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Deadly dose: Rensselaer heparin expert helps uncover source of lethal contamination
2. Trustee makes donation to start new solar energy research center at Rensselaer
3. Rutgers Genetics receives $7.8 million for autism research
4. Herr receives Heinz Award for Technology, the Economy and Employment
5. UCI receives $5M from Edwards Lifesciences
6. Yu receives research funding from the Wallace H. Coulter Foundation
7. UGA Odum School of Ecology professor receives grant to study West Nile Virus in NYC
8. UC Riverside biologist receives prestigious MacArthur Fellowship
9. UC Irvine receives $2.18M to explore nano advancements in DNA sequencing
10. Penn biochemist receives NIH New Innovators Award
11. NYUs Center for Genomics & Systems Biology receives $4.4 million NSF grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2015)... 2015  Alere Inc. (NYSE: ALR), a global ... for the quarter ended December 31, 2014. ... of Alere said, "We made substantial progress in ... global leader in rapid diagnostics and delivering against ... divestiture in early January enabled us to substantially ...
(Date:2/5/2015)... , 5. Februar 2015 ... spezialisiertes Logistikunternehmen und hat eine neue Marketingkampagne ... Logistikfirma (Clinical Logistics Organization – CLO) der ... Kampagne lautet First , mit Schwerpunkt ... Foto: http://photos.prnewswire.com/prnh/20150205/173753 Logo ...
(Date:2/5/2015)... 26, 2015   Epic Sciences , a precision diagnostics ... that Murali Prahalad , Ph.D., president and CEO, is ... (PMWC) 2015: Silicon Valley, which is taking place at ... on January 26-28, 2015. Dr. ... as Biomarkers." Last year, Epic Sciences was a finalist in ...
Breaking Biology News(10 mins):Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35Alere Inc. Announces Fourth Quarter 2014 Results 36
... have made an "a-maize-ing" discovery that could lead to ... new research report published in the March 2010 issue ... scientists used tropical maize from Mexico and Thailand to ... flowering time (called the "photoperiod response"). This discovery may ...
... developed by Japanese scientists may revolutionize how and when ... published online in The FASEB Journal ( ... spinal fluid known to be one of the main ... patients: high molecular weight A-Beta oligomers. This tool, ...
... happens in science that what you throw away turns out ... not for long. The Rice assistant professor in chemical ... in a scaffold, and he discarded the sticky substance secreted ... so I threw the plates away," said Nagrath, then a ...
Cached Biology News:'A-maize-ing' discovery could lead to higher corn yields for food, feed and fuel 2New test takes guesswork out of diagnosing early-stage Alzheimer's disease 2Your fat may help you heal 2
(Date:2/27/2015)... 2015 Immunovaccine Inc. (“Immunovaccine” or the ... fraudulent press release disseminated this morning by PR Web, ... This press release states that Immunovaccine has entered into ... press release did not originate from Immunovaccine and there ... press release. Please note that all official statements ...
(Date:2/27/2015)... Scotia (PRWEB) February 27, 2015 ... vaccine and immunotherapy company, today announced that the ... application for Fast Track designation and Phase I ... in conjunction with the mutual co-development agreement signed ... obtained Fast Track designation for the DPX-Survivac. , ...
(Date:2/27/2015)... 2015 Cytokinetics, Incorporated (Nasdaq: CYTK) announced ... with patients and health care advocates in the United ... Day®. Rare Disease Day is dedicated to elevating ... the special challenges faced by patients with rare diseases ... proud to stand alongside patients and caregivers representing the ...
(Date:2/26/2015)... , Feb. 26, 2015  23andMe, the leading personal ... Black as Privacy Officer and Corporate Counsel. Black ... privacy laws as well as health care regulations. As ... will be responsible for reviewing, updating and enhancing the ... U.S. and abroad. She joined the company January 5, ...
Breaking Biology Technology:Immunovaccine Disclaims Hoax Press Release 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 623andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2
... California, October 11 IsoTis, Inc.,(NASDAQ: ISOT ) ... the special meeting of stockholders it called to approve,the ... IART ) ("Integra") pursuant to an agreement and plan ... special meeting of stockholders was held at 9 a.m. ...
... Inc.,has recently released the first (40) in a series ... available through subscription to Timely,Data Resources, Incidence and Prevalence ... offer a quick and,affordable overview of the critical facts ... pages in length, and covers the following information: ...
... Thermo Fisher,Scientific Inc. (NYSE: TMO ), ... plan to construct an $11 million, state-of-the-art BioCenter,for ... related,products at the site of its existing bioprocess ... investment is a response to the increasing demand ...
Cached Biology Technology:IsoTis Adjourns Special Meeting to October 23, 2007 2IsoTis Adjourns Special Meeting to October 23, 2007 3IsoTis Adjourns Special Meeting to October 23, 2007 4Thermo Fisher Scientific to Expand Manufacturing Operation for Single-Use Bioprocessing Containers 2Thermo Fisher Scientific to Expand Manufacturing Operation for Single-Use Bioprocessing Containers 3Thermo Fisher Scientific to Expand Manufacturing Operation for Single-Use Bioprocessing Containers 4
These disposable button tethers are designed for rat infusion studies lasting more than 2 weeks. After one to two weeks the subcutaneous tissue will grow into the Dacron mesh, making the sutures irre...
Newborn Bovine Serum Heat-Inactivated...
Mycoplasma and virus tested...
... 10X BlueJuice Gel Loading ... easy loading and tracking ... agarose or native polyacrylamide ... features higher density sucrose ...
Biology Products: